<DOC>
	<DOCNO>NCT02136849</DOCNO>
	<brief_summary>Intellectual disability ( ID ) moderate severe affect one child 250 , 3000 4000 new case year . Chromosomal molecular pathology cause identify half case current technique . Studies show de novo mutation common many different gene . The `` exome '' approach high-throughput sequencing ( NGS ) emerge technique choice identify compare exome child parent . We wish evaluate approach contribution diagnostic management 50 patient DI see genetics 6 CHU Great West . Genomics platform IBISA / Biogenouest provide technological bioinformatics support project .</brief_summary>
	<brief_title>Inter-regional Project Great Western Exploration Approach Exome Molecular Causes Severe Intellectual Disability Isolated Syndromic</brief_title>
	<detailed_description />
	<mesh_term>Intellectual Disability</mesh_term>
	<criteria>Patients severe intellectual disability ( IQ &lt; 35 ) moderate ( IQ &lt; 50 ) isolate syndromic presentation undiagnosed . The diagnosis establish genetic counseling 6 CHU interregion Lack family history ( parent ) . We interested project patient family history order increase probability identify de novo mutation . We however exclude hypothesis patient mechanism recessive autosomal Xlinked . Recruitment 6 CHU HUGO . Patients require see genetics 6 CHU interregion . Molecular analyzes Fragile X syndrome CGH technique must negative . Indication sequence exomique adopt Scientific Committee . The Scientific Committee HUGODIMS project role select patient whose DNA study order optimize chance success sequence . This selection must take account clinical parameter , also genetic parameter ( potential inbreeding ) . The file select videoconferencing end monthly meeting CLAD . The methodologist study invite videoconferencing . specific consent obtain study . Parents patient moderate severe intellectual disability disagree prefer hypothesis de novo mutation recessive transmission mechanism . Form known syndromic diagnosis target molecular study ( clinical sign ) . Cause molecular DI identify target molecular analysis CGH . Explicit refusal participate study patient , parent , one two parent . Any indication intellectual disability . The parent patient patient may remove .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>severe intellectual disability , genetic , de novo exome</keyword>
</DOC>